Pharmaceutical manufacturing

FILE - This May 1, 2018 file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck & Co. reports earnings Friday, Feb. 1, 2019. (AP Photo/Seth Wenig, File)
February 01, 2019 - 8:58 am
Higher medicine sales and lower restructuring and other costs lifted drugmaker Merck to a $1.83 billion profit in the fourth quarter, as it edged past Wall Street expectations. The maker of blockbuster cancer drug Keytruda and Januvia diabetes pills lost $1.05 billion a year earlier, when it had a...
Read More
FILE - This May 1, 2018 file photo shows Merck corporate headquarters in Kenilworth, N.J. Merck & Co. reports earnings Friday, Feb. 1, 2019. (AP Photo/Seth Wenig, File)
February 01, 2019 - 7:42 am
Higher medicine sales and lower restructuring and other costs lifted drugmaker Merck to a $1.83 billion profit in the third quarter, as it edged past Wall Street expectations. The maker of blockbuster cancer drug Keytruda and Januvia diabetes pills lost $1.05 billion a year earlier, when it had a $...
Read More
FILE- In this Oct. 26, 2018, file photo Health and Human Services Secretary Alex Azar speaks about proposed reforms to Medicare Part B drug pricing policies at the Brookings Institute in Washington. The Trump administration says it is moving ahead with a plan to let patients directly receive prescription drug discounts negotiated behind-the-scenes between drugmakers, middlemen, and insurers. Azar said Thursday, Jan. 31, 2019, the proposed regulation would encourage the major industry players to channel any such discounts to consumers when they purchase their prescriptions. (AP Photo/Alex Brandon, File)
February 01, 2019 - 1:00 am
WASHINGTON (AP) — The Trump administration has unveiled a plan to channel now-hidden prescription drug rebates directly to patients, saying it would bypass middlemen and lower prices for consumers. The proposed regulation from Health and Human Services Secretary Alex Azar would eliminate behind-the...
Read More
FILE- In this Oct. 26, 2018, file photo Health and Human Services Secretary Alex Azar speaks about proposed reforms to Medicare Part B drug pricing policies at the Brookings Institute in Washington. The Trump administration says it is moving ahead with a plan to let patients directly receive prescription drug discounts negotiated behind-the-scenes between drugmakers, middlemen, and insurers. Azar said Thursday, Jan. 31, 2019, the proposed regulation would encourage the major industry players to channel any such discounts to consumers when they purchase their prescriptions. (AP Photo/Alex Brandon, File)
February 01, 2019 - 12:50 am
WASHINGTON (AP) — The Trump administration has unveiled a plan to channel now-hidden prescription drug rebates directly to patients, saying it would bypass middlemen and lower prices for consumers. The proposed regulation from Health and Human Services Secretary Alex Azar would eliminate behind-the...
Read More
FILE- In this Oct. 26, 2018, file photo Health and Human Services Secretary Alex Azar speaks about proposed reforms to Medicare Part B drug pricing policies at the Brookings Institute in Washington. The Trump administration says it is moving ahead with a plan to let patients directly receive prescription drug discounts negotiated behind-the-scenes between drugmakers, middlemen, and insurers. Azar said Thursday, Jan. 31, 2019, the proposed regulation would encourage the major industry players to channel any such discounts to consumers when they purchase their prescriptions. (AP Photo/Alex Brandon, File)
January 31, 2019 - 7:55 pm
WASHINGTON (AP) — The Trump administration Thursday unveiled a plan to channel now-hidden prescription drug rebates directly to patients, saying it would bypass middlemen and lower prices for consumers. The proposed regulation from Health and Human Services Secretary Alex Azar would eliminate...
Read More
FILE- In this Oct. 26, 2018, file photo Health and Human Services Secretary Alex Azar speaks about proposed reforms to Medicare Part B drug pricing policies at the Brookings Institute in Washington. The Trump administration says it is moving ahead with a plan to let patients directly receive prescription drug discounts negotiated behind-the-scenes between drugmakers, middlemen, and insurers. Azar said Thursday, Jan. 31, 2019, the proposed regulation would encourage the major industry players to channel any such discounts to consumers when they purchase their prescriptions. (AP Photo/Alex Brandon, File)
January 31, 2019 - 7:12 pm
WASHINGTON (AP) — The Trump administration Thursday unveiled a plan to channel now-hidden prescription drug rebates directly to patients, saying it would bypass middlemen and lower prices for consumers. The proposed regulation from Health and Human Services Secretary Alex Azar would eliminate...
Read More
FILE- In this Oct. 26, 2018, file photo Health and Human Services Secretary Alex Azar speaks about proposed reforms to Medicare Part B drug pricing policies at the Brookings Institute in Washington. The Trump administration says it is moving ahead with a plan to let patients directly receive prescription drug discounts negotiated behind-the-scenes between drugmakers, middlemen, and insurers. Azar said Thursday, Jan. 31, 2019, the proposed regulation would encourage the major industry players to channel any such discounts to consumers when they purchase their prescriptions. (AP Photo/Alex Brandon, File)
January 31, 2019 - 6:24 pm
WASHINGTON (AP) — The Trump administration Thursday unveiled a plan to channel now-hidden prescription drug discounts directly to patients, saying that would eventually lower prices for consumers. The proposed regulation from Health and Human Services Secretary Alex Azar aims to eliminate behind-...
Read More
FILE- In this Oct. 26, 2018, file photo Health and Human Services Secretary Alex Azar speaks about proposed reforms to Medicare Part B drug pricing policies at the Brookings Institute in Washington. The Trump administration says it is moving ahead with a plan to let patients directly receive prescription drug discounts negotiated behind-the-scenes between drugmakers, middlemen, and insurers. Azar said Thursday, Jan. 31, 2019, the proposed regulation would encourage the major industry players to channel any such discounts to consumers when they purchase their prescriptions. (AP Photo/Alex Brandon, File)
January 31, 2019 - 5:02 pm
WASHINGTON (AP) — The Trump administration says it is moving ahead with a plan to channel behind-the-scenes prescription drug discounts directly to consumers. Health and Human Services Secretary Alex Azar said Thursday his proposed regulation would encourage drugmakers, middlemen and insurers to...
Read More
January 31, 2019 - 4:55 pm
WASHINGTON (AP) — The Trump administration says it is moving ahead with a plan to channel behind-the-scenes prescription drug discounts directly to consumers. Health and Human Services Secretary Alex Azar said Thursday his proposed regulation would encourage drugmakers, middlemen and insurers to...
Read More
Trader Michael Unkonis, center, works on the floor of the New York Stock Exchange, Tuesday, Jan. 29, 2019. Stocks are opening slightly higher on Wall Street as several big U.S. companies reported solid results for the latest quarter. (AP Photo/Richard Drew)
January 29, 2019 - 3:44 pm
NEW YORK (AP) — Major U.S. stock indexes were mostly lower late Tuesday afternoon, placing the market on course for its second decline in a row. Losses in technology and media companies outweighed gains in industrial and health care stocks. Early gains faded as investors assessed a mixed bag of...
Read More

Pages